Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Testing effectiveness (Phase 2)Study completedNCT00024089What this trial is testingGefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT01772004What this trial is testingAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)Who this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Study completedNCT04592484What this trial is testingA First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid TumorsWho this might be right forAdvanced Solid Tumor Codiak BioSciences 27
Not applicableUnknownNCT05760391What this trial is testingIO Plus Radiotherapy in Patients With Advanced ESCC.Who this might be right forMetastatic Esophageal Squamous Cell Carcinoma Fudan University 100
Testing effectiveness (Phase 2)Ended earlyNCT02449681What this trial is testingStudy for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or SkinWho this might be right forMetastatic Head-and-neck Squamous-cell Carcinoma Rain Oncology Inc 30
Testing effectiveness (Phase 2)Study completedNCT01044433What this trial is testingCapecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and NeckWho this might be right forHead and Neck CancerMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult Primary+17 more Abramson Cancer Center at Penn Medicine 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT03485209What this trial is testingEfficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsWho this might be right forColorectal NeoplasmsCarcinoma, Non-Small-Cell LungExocrine Pancreatic Cancer+1 more Seagen, a wholly owned subsidiary of Pfizer 350
Not applicableStudy completedNCT01015963What this trial is testingStudying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871Who this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 69
Not applicableEnded earlyNCT03886181What this trial is testingAlpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)Who this might be right forSkin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm Alpha Tau Medical LTD. 2
Testing effectiveness (Phase 2)Study completedNCT00756444What this trial is testingPhase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckWho this might be right forSquamous Cell Carcinoma of Head and Neck Amgen 67
Early research (Phase 1)Looking for participantsNCT06778863What this trial is testingCLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationWho this might be right forAdvanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+8 more Clasp Therapeutics, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT01178944What this trial is testingPralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal Undifferentiated CarcinomaGastric Adenocarcinoma+14 more Roswell Park Cancer Institute 35
Testing effectiveness (Phase 2)Looking for participantsNCT06682793What this trial is testingEvaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more A2 Biotherapeutics Inc. 240
Testing effectiveness (Phase 2)UnknownNCT04146181What this trial is testingSafety and Efficacy of SCT-I10A in Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma Sinocelltech Ltd. 103
Early research (Phase 1)Study completedNCT04641871What this trial is testingSym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesWho this might be right forMetastatic CancerSolid Tumor Symphogen A/S 78
Testing effectiveness (Phase 2)Study completedNCT00012363What this trial is testingS0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the EsophagusWho this might be right forEsophageal CancerGastric Cancer SWOG Cancer Research Network 61
Large-scale testing (Phase 3)Study completedNCT02347332What this trial is testingPhase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck CancerWho this might be right forRecurrent or Metastatic Head and Neck Carcinoma Pierre Fabre Medicament 459
Testing effectiveness (Phase 2)Looking for participantsNCT07408063What this trial is testingA Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)Who this might be right forRecurrent/Metastatic Head and Neck Squamous Cell Carcinoma University Health Network, Toronto 30
Not applicableActive Not RecruitingNCT05812027What this trial is testingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsWho this might be right forHead and Neck CancerCervical CancerNon Small Cell Lung Cancer+4 more TScan Therapeutics, Inc. 1,150